Shanghai Labway Clinical Laboratory Co., Ltd (SHE:301060)

SHE:301060 Revenue

Shanghai Labway Clinical Laboratory had revenue of 287.16M CNY in the quarter ending March 31, 2026, a decrease of -18.16%. This brings the company's revenue in the last twelve months to 1.38B, down -16.44% year-over-year. In the year 2025, Shanghai Labway Clinical Laboratory had annual revenue of 1.45B, down -16.88%.

• Revenue (ttm): 1.38B
• Revenue Growth: -16.44%
• P/S Ratio: 3.08
• Revenue / Employee: 1.01M
• Employees: 1,365
• Market Cap: 4.26B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.45B	-294.15M	-16.88%
Dec 31, 2024	1.74B	67.81M	4.05%
Dec 31, 2023	1.67B	-2.52B	-60.13%
Jan 1, 2023	4.20B	2.42B	136.14%
Jan 1, 2022	1.78B	540.14M	43.62%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 16, 2026

Data Sources Report a data error